Showing results (151-160 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|October 19, 2018
Osimertinib Quantitative and Gene Variation Analyses in Cerebrospinal Fluid and Plasma of a Non-small Cell Lung Cancer Patient with Leptomeningeal MetastasesYuanyuan Song, Peng Liu, Yu Huang, et al.Current Cancer Drug Targets|March 14, 2008
p53: a guide to apoptosisErik Meulmeester, Aart G JochemsenCurrent Cancer Drug Targets|March 14, 2008
Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumorsDomagoj VucicCurrent Cancer Drug Targets|September 28, 2007
Stem cells, cancer, liver, and liver cancer stem cells: finding a way out of the labyrinthA C Piscaglia, T D Shupe, B E Petersen, et al.Current Cancer Drug Targets|July 20, 2006
Targeted therapies in non-small cell lung cancer: proven concepts and unfulfilled promisesJutta Auberger, Judith Loeffler-Ragg, Walter Wurzer, et al.Current Cancer Drug Targets|October 5, 2006
Protein tyrosine phosphatases, new targets for cancer therapyDavid Easty, William Gallagher, D C BennettCurrent Cancer Drug Targets|October 5, 2006
Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDSHironori Harada, Yuka Harada, Akiro KimuraCurrent Cancer Drug Targets|September 24, 2004
Two-domain vascular disruptive agents in cancer therapyStanislaw SzalaCurrent Cancer Drug Targets|September 24, 2004
TSC-22 (TGF-beta stimulated clone-22): a novel molecular target for differentiation-inducing therapy in salivary gland cancerH Kawamata, T Fujimori, Y ImaiCurrent Cancer Drug Targets|April 7, 2005
NO news is not necessarily good news in cancerSuhendan Ekmekcioglu, Chi-Hui Tang, Elizabeth A GrimmPageof 187